Inventor
Martyn Botfield
Inventor
Concord, MA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
Y02PClimate change mitigation technologies in the production or processing of goods9%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C40BCombinatorial chemistry1%
PatentTitleYear
10,646,481Pharmaceutical composition and administrations thereof20209,751,839'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20179,371,287'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20168,999,976'Modulators of cystic fibrosis transmembrane conductance regulator'20158,969,382'Modulators of cystic fibrosis transmembrane conductance regulator'20158,835,639'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20148,802,700'Modulators of ATP-Binding Cassette transporters'20148,796,308'Modulators of cystic fibrosis transmembrane conductance regulator'20148,785,640'Modulators of cystic fibrosis transmembrane conductance regulator'20148,765,957'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20148,633,189'Modulators of cystic fibrosis transmembrane conductance regulator'20148,614,327'Modulators of ATP-binding cassette transporters'20138,614,325'Modulators of cystic fibrosis transmembrane conductance regulator'20138,604,203'Modulators of cystic fibrosis transmembrane conductance regulator'20138,598,205'Modulators of cystic fibrosis transmembrane conductance regulator'20138,513,282'Modulators of cystic fibrosis transmembrane conductance regulator'20138,476,442'Process for making modulators of cystic fibrosis transmembrane conductance regulator'20138,436,014'Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide'20138,367,660'Modulators of cystic fibrosis transmembrane conductance regulator'20136,949,655'Acyclic piperidine derivatives'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2013Patents assigned to BOTFIELD MARTYN (5)· patent assignee history
2005Based in Boston, MA, US· patent location history
2013–2020Patents assigned to VERTEX PHARMA (19)· patent assignee history
2013Patents assigned to GROOTENHUIS PETER D J (5)· patent assignee history
2013–2014Patents assigned to BINCH HAYLEY (4)· patent assignee history
2013–2014Patents assigned to FANNING LEV T D (4)· patent assignee history
2013–2020Based in Concord, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 19 | 2013–2020 |
| BOTFIELD MARTYNself | 5 | 2005–2013 |
| GROOTENHUIS PETER D J | 5 | 2013 |
| BINCH HAYLEY | 4 | 2013–2014 |
| FANNING LEV T D | 4 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Concord, Massachusetts, US | 19 | 2013–2020 |
| Boston, Massachusetts, US | 1 | 2005 |